Gurpreet Singh Lamba, MBBS

Gurpreet Lamba practices at Regional Cancer Care Associates in Teaneck, New Jersey.

Gurpreet Lamba's NPI, 1427294271, was assigned on December 29, 2008. Gurpreet Lamba graduated from Nehru Medical College/ R. Gandhi HS University in 2005. Gurpreet Lamba's Vermont license number on file is 042.0012435.

Gurpreet Lamba's primary practice is Regional Cancer Care Associates, at 500 Frank W Burr Blvd, Teaneck, NJ 07666 in Bergen County. The practice phone is (732) 367-1535.

Gurpreet Lamba's primary practice is Regional Cancer Care Associates in Teaneck, New Jersey. Gurpreet Lamba is also affiliated with Jersey Shore University Medical Center. The medical group on file is Regional Cancer Care Associates. Dmand AI also links Gurpreet Lamba to 4 more hospitals, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Gurpreet Lamba practices, 5 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Gurpreet Lamba's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Gurpreet Lamba is board certified in hematology by the American Board of Internal Medicine. Dmand AI has Gurpreet Lamba's licenses on file in 3 states: Vermont, New Jersey and New York.

Dmand AI lists breast cancer, chronic anemia, chronic embolism thrombosis, chronic leukemia, colorectal cancer, deep vein thrombosis (DVT), immune deficiency disease and lung cancer among the conditions Gurpreet Lamba treats.

CMS data shows 207,401 Medicare services from Gurpreet Lamba across 52 procedure codes in 2024, for 1,072 Medicare patients. Medicare paid $2,744,370 for them.

CMS counts 1,072 Medicare patients who saw Gurpreet Lamba in 2024. The largest group is 75 to 84, with 399 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 13% are also on Medicaid. Their average risk score is 2.47, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Gurpreet Lamba's median patient age at 71, with 51% women.

In 2024, Gurpreet Lamba wrote 1,132 Medicare Part D claims for 239 patients. 75% of them were for generic drugs. CMS names the drug for 778 of them, across 25 drugs with 11 or more claims each, at $1,489,608 in total drug cost. In 2023, CMS named 665 claims across 23 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 85 out of 100 for Gurpreet Lamba for performance year 2024, reported individually. Gurpreet Lamba accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Gurpreet Lamba as offering telehealth.

Dmand AI links 16 papers to Gurpreet Lamba, published from 2011 to 2021. The most frequent topics are Biopsy, Needle, Cholangiopancreatography, Endoscopic Retrograde and Gastrointestinal Hemorrhage. Gurpreet Lamba has published most often in Trop Gastroenterol. Gurpreet Lamba's most frequent co-authors are Dhaval Rameshchandra Shah, MD, Steven Ades, MD and Zubin Agarwal, MD, MPH.

Dmand AI links Gurpreet Lamba to 3 clinical trials. Conditions studied include Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myeloid, Acute and Precursor Cell Lymphoblastic Leukemia-Lymphoma. National Cancer Institute (NCI) sponsors the most, 2.

CMS Open Payments shows 1,510 general payments to Gurpreet Lamba from 98 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 49% of the total. AstraZeneca Pharmaceuticals LP paid the most, $16,891.

Gurpreet Lamba graduated from Nehru Medical College/ R. Gandhi HS University in 2005. Gurpreet Lamba is a member of ASH.

Gurpreet Lamba is in network with 17 carriers, including Elevance, Aetna and United Healthcare. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.